Alterations of Hemoglobin Fractionation in a Sickle Cell Disease Patient on Voxelotor Therapy
Sign Up to like & getrecommendations! Published in 2020 at "American Journal of Clinical Pathology"
DOI: 10.1093/ajcp/aqaa161.220
Abstract: Voxelotor is a molecule that allosterically binds to the alpha-chain of hemoglobin, resulting in increased oxygen affinity. This allosteric inhibition leads to prevention of hemoglobin polymerization and sickling of red blood cells in response to… read more here.
Keywords: fractionation; treatment; voxelotor; therapy ... See more keywords